PGNY
Progyny, Inc.
Price Chart
Latest Quote
$24.21
Current Price| Previous Close | $23.87 |
| Open | $23.87 |
| Day High | $24.30 |
| Day Low | $23.53 |
| Volume | 1,565,477 |
Stock Information
| Shares Outstanding | 86.21M |
| Total Debt | $28.15M |
| Cash Equivalents | $345.21M |
| Revenue | $1.27B |
| Net Income | $56.57M |
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Market Cap | $2.09B |
| P/E Ratio | 39.05 |
| EPS (TTM) | $0.62 |
| Exchange | NMS |
📊 Custom Metrics & Score
Score: 29/42| Debt to Equity | 0.05 |
| Debt to Earnings | 0.08 |
| Current Ratio | 2.80 |
| Quick Ratio | 2.75 |
| Avg Revenue Growth | 33.29% |
| Profit Margin | 4.66% |
| Return on Equity | 12.87% |
| Avg FCF Growth | 156.63% |
| FCF Yield | 8.32% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $24.21 | 1,565,477 |
| 2026-01-30 | $23.87 | 1,418,300 |
| 2026-01-29 | $24.12 | 1,449,000 |
| 2026-01-28 | $24.53 | 1,503,400 |
| 2026-01-27 | $24.25 | 1,176,200 |
| 2026-01-26 | $24.84 | 1,582,500 |
| 2026-01-23 | $25.22 | 1,953,700 |
| 2026-01-22 | $25.00 | 1,430,100 |
| 2026-01-21 | $25.45 | 1,182,200 |
| 2026-01-20 | $25.38 | 1,675,400 |
| 2026-01-16 | $24.52 | 1,348,600 |
| 2026-01-15 | $24.31 | 1,419,500 |
| 2026-01-14 | $26.12 | 1,537,700 |
| 2026-01-13 | $25.24 | 2,558,700 |
| 2026-01-12 | $28.42 | 1,660,200 |
| 2026-01-09 | $26.99 | 1,345,300 |
| 2026-01-08 | $27.43 | 1,510,300 |
| 2026-01-07 | $26.80 | 1,274,600 |
| 2026-01-06 | $26.67 | 1,621,800 |
| 2026-01-05 | $26.66 | 1,301,700 |
About Progyny, Inc.
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. The company offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. It also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services. In addition, the company offers assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
📰 Latest News
Assessing Progyny (PGNY) Valuation After Recent Share Pullback And 3‑Month Rebound
Simply Wall St. • 2026-02-01T15:12:15Z
3 Russell 2000 Stocks We Think Twice About
StockStory • 2026-01-30T04:32:15Z
Progyny price target raised to $35 from $30 at BTIG
TipRanks • 2026-01-22T12:20:50Z
Progyny, Inc. (PGNY) Supported by Analysts as Earnings Visibility Improves
Insider Monkey • 2026-01-22T08:23:14Z
Progyny (PGNY) Stock Is Up, What You Need To Know
StockStory • 2026-01-20T20:10:50Z
Can Progyny’s (PGNY) Modest Guidance Raise Redefine Its Demand Resilience Narrative?
Simply Wall St. • 2026-01-17T05:12:03Z
1 Profitable Stock to Consider Right Now and 2 We Avoid
StockStory • 2026-01-16T04:41:31Z
3 Hyped Up Stocks That Concern Us
StockStory • 2026-01-15T04:35:56Z
Zacks Industry Outlook Highlights Medpace, Enhabit and Progyny
Zacks • 2026-01-12T15:07:00Z
Progyny, Inc.'s (NASDAQ:PGNY) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?
Simply Wall St. • 2026-01-11T14:07:58Z
Income Statement (Annual)
Revenue
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Reconciled Cost Of Revenue | $913,858,000 | $849,799,000 | $619,588,000 | $388,486,000 |
| Cost Of Revenue | $913,858,000 | $849,799,000 | $619,588,000 | $388,486,000 |
| Total Revenue | $1,167,221,000 | $1,088,598,000 | $786,913,000 | $500,621,000 |
| Operating Revenue | $1,167,221,000 | $1,088,598,000 | $786,913,000 | $500,621,000 |
Expenses
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Expenses | $1,099,766,000 | $1,026,414,000 | $763,572,000 | $468,281,000 |
| Net Non Operating Interest Income Expense | $15,747,000 | $8,507,000 | $1,100,000 | $461,000 |
| Operating Expense | $185,908,000 | $176,615,000 | $143,984,000 | $79,795,000 |
| Selling And Marketing Expense | $63,948,000 | $59,488,000 | $45,657,000 | $20,179,000 |
| General And Administrative Expense | $121,960,000 | $117,127,000 | $98,327,000 | $59,616,000 |
| Other Income Expense | - | $5,203,000 | $286,000 | $-366,000 |
| Other Non Operating Income Expenses | - | $5,203,000 | $286,000 | $-366,000 |
| Total Other Finance Cost | - | $-3,304,000 | $-814,000 | $-461,000 |
Income & Earnings
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $54,336,000 | $62,037,000 | $30,358,000 | $65,769,000 |
| Net Interest Income | $15,747,000 | $8,507,000 | $1,100,000 | $461,000 |
| Interest Income | $15,747,000 | $8,507,000 | $1,100,000 | - |
| Normalized Income | $54,336,000 | $62,037,000 | $30,358,000 | $65,769,000 |
| Net Income From Continuing And Discontinued Operation | $54,336,000 | $62,037,000 | $30,358,000 | $65,769,000 |
| Total Operating Income As Reported | $67,455,000 | $62,184,000 | $23,341,000 | $32,340,000 |
| Net Income Common Stockholders | $54,336,000 | $62,037,000 | $30,358,000 | $65,769,000 |
| Net Income | $54,336,000 | $62,037,000 | $30,358,000 | $65,769,000 |
| Net Income Including Noncontrolling Interests | $54,336,000 | $62,037,000 | $30,358,000 | $65,769,000 |
| Net Income Continuous Operations | $54,336,000 | $62,037,000 | $30,358,000 | $65,769,000 |
| Pretax Income | $83,202,000 | $70,691,000 | $24,441,000 | $32,435,000 |
| Interest Income Non Operating | $15,747,000 | $8,507,000 | $1,100,000 | - |
| Operating Income | $67,455,000 | $62,184,000 | $23,341,000 | $32,340,000 |
| Gross Profit | $253,363,000 | $238,799,000 | $167,325,000 | $112,135,000 |
Per Share Metrics
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Diluted EPS | $0.57 | $0.62 | $0.30 | $0.66 |
| Basic EPS | $0.59 | $0.65 | $0.33 | $0.74 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $70,630,000 | $64,465,000 | $24,942,000 | $33,641,000 |
| Reconciled Depreciation | $3,175,000 | $2,281,000 | $1,601,000 | $1,301,000 |
| EBITDA (Bullshit earnings) | $70,630,000 | $64,465,000 | $24,942,000 | $33,641,000 |
| EBIT | $67,455,000 | $62,184,000 | $23,341,000 | $32,340,000 |
| Diluted Average Shares | $95,448,357 | $100,672,399 | $99,957,173 | $100,358,047 |
| Basic Average Shares | $91,481,995 | $95,021,175 | $92,195,068 | $89,105,562 |
| Diluted NI Availto Com Stockholders | $54,336,000 | $62,037,000 | $30,358,000 | $65,769,000 |
| Tax Provision | $28,866,000 | $8,654,000 | $-5,917,000 | $-33,334,000 |
| Selling General And Administration | $185,908,000 | $176,615,000 | $143,984,000 | $79,795,000 |
| Other Gand A | $121,960,000 | $117,127,000 | $98,327,000 | $59,616,000 |
Balance Sheet (Annual)
Assets
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Tangible Assets | $405,225,000 | $541,549,000 | $364,989,000 | $239,343,000 |
| Total Assets | $607,102,000 | $756,620,000 | $542,986,000 | $358,065,000 |
| Total Non Current Assets | $134,381,000 | $116,213,000 | $109,130,000 | $99,526,000 |
| Other Non Current Assets | $2,977,000 | $3,395,000 | $3,988,000 | $2,941,000 |
| Non Current Deferred Assets | $84,933,000 | $73,120,000 | $77,889,000 | $71,274,000 |
| Non Current Deferred Taxes Assets | $84,933,000 | $73,120,000 | $77,889,000 | $71,274,000 |
| Goodwill And Other Intangible Assets | $16,837,000 | $11,880,000 | $11,979,000 | $12,479,000 |
| Other Intangible Assets | $1,303,000 | - | $99,000 | $599,000 |
| Current Assets | $472,721,000 | $640,407,000 | $433,856,000 | $258,539,000 |
| Other Current Assets | $9,443,000 | $27,451,000 | $4,489,000 | $4,564,000 |
| Receivables | $235,324,000 | $241,869,000 | $240,067,000 | $134,557,000 |
| Accounts Receivable | $235,324,000 | $241,869,000 | $240,067,000 | $134,557,000 |
| Allowance For Doubtful Accounts Receivable | $-56,355,000 | $-46,636,000 | $-28,328,000 | $-17,379,000 |
| Gross Accounts Receivable | $291,679,000 | $288,505,000 | $268,395,000 | $151,936,000 |
| Cash Cash Equivalents And Short Term Investments | $227,954,000 | $371,087,000 | $189,300,000 | $119,418,000 |
| Cash And Cash Equivalents | $162,314,000 | $97,296,000 | $120,078,000 | $91,413,000 |
| Prepaid Assets | - | - | - | $4,564,000 |
Debt
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Debt | $19,272,000 | $19,390,000 | $7,713,000 | $8,650,000 |
| Long Term Debt And Capital Lease Obligation | $16,413,000 | $17,241,000 | $6,482,000 | $7,419,000 |
| Current Debt And Capital Lease Obligation | $2,859,000 | $2,149,000 | $1,231,000 | $1,231,000 |
Liabilities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $185,040,000 | $203,191,000 | $166,018,000 | $106,243,000 |
| Total Non Current Liabilities Net Minority Interest | $16,413,000 | $17,241,000 | $6,482,000 | $7,419,000 |
| Current Liabilities | $168,627,000 | $185,950,000 | $159,536,000 | $98,824,000 |
| Other Current Liabilities | $5,299,000 | $1,183,000 | $1,169,000 | $2,172,000 |
| Payables And Accrued Expenses | $145,897,000 | $170,750,000 | $149,430,000 | $85,332,000 |
| Payables | $127,218,000 | $155,720,000 | $140,426,000 | $81,397,000 |
| Other Payable | $32,121,000 | $30,294,000 | $31,139,000 | $19,998,000 |
| Accounts Payable | $95,097,000 | $125,426,000 | $109,287,000 | $61,399,000 |
Equity
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Common Stock Equity | $422,062,000 | $553,429,000 | $376,968,000 | $251,822,000 |
| Total Equity Gross Minority Interest | $422,062,000 | $553,429,000 | $376,968,000 | $251,822,000 |
| Stockholders Equity | $422,062,000 | $553,429,000 | $376,968,000 | $251,822,000 |
| Gains Losses Not Affecting Retained Earnings | $39,000 | $2,819,000 | $501,000 | $-93,000 |
| Other Equity Adjustments | $39,000 | $2,819,000 | $501,000 | $-93,000 |
| Retained Earnings | $144,307,000 | $89,971,000 | $27,934,000 | $-2,424,000 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Treasury Shares Number | $12,998,173 | $615,980 | $615,980 | $615,980 |
| Ordinary Shares Number | $85,310,698 | $96,348,522 | $93,301,156 | $91,088,781 |
| Share Issued | $98,308,871 | $96,964,502 | $93,917,136 | $91,704,761 |
| Tangible Book Value | $405,225,000 | $541,549,000 | $364,989,000 | $239,343,000 |
| Invested Capital | $422,062,000 | $553,429,000 | $376,968,000 | $251,822,000 |
| Working Capital | $304,094,000 | $454,457,000 | $274,320,000 | $159,715,000 |
| Capital Lease Obligations | $19,272,000 | $19,390,000 | $7,713,000 | $8,650,000 |
| Total Capitalization | $422,062,000 | $553,429,000 | $376,968,000 | $251,822,000 |
| Treasury Stock | $303,889,000 | $1,009,000 | $1,009,000 | $1,009,000 |
| Additional Paid In Capital | $581,596,000 | $461,639,000 | $349,533,000 | $255,339,000 |
| Capital Stock | $9,000 | $9,000 | $9,000 | $9,000 |
| Common Stock | $9,000 | $9,000 | $9,000 | $9,000 |
| Long Term Capital Lease Obligation | $16,413,000 | $17,241,000 | $6,482,000 | $7,419,000 |
| Current Capital Lease Obligation | $2,859,000 | $2,149,000 | $1,231,000 | $1,231,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $14,572,000 | $11,868,000 | $7,706,000 | $10,089,000 |
| Current Accrued Expenses | $18,679,000 | $15,030,000 | $9,004,000 | $3,935,000 |
| Goodwill | $15,534,000 | $11,880,000 | $11,880,000 | $11,880,000 |
| Net PPE | $29,634,000 | $27,818,000 | $15,274,000 | $12,832,000 |
| Accumulated Depreciation | $-8,368,000 | $-5,301,000 | $-3,119,000 | $-2,563,000 |
| Gross PPE | $38,002,000 | $33,119,000 | $18,393,000 | $15,395,000 |
| Leases | $4,397,000 | $3,733,000 | $3,394,000 | $3,110,000 |
| Other Properties | $17,251,000 | $17,605,000 | $6,903,000 | $7,805,000 |
| Machinery Furniture Equipment | $16,354,000 | $11,781,000 | $8,096,000 | $4,480,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $65,640,000 | $273,791,000 | $69,222,000 | $28,005,000 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | $173,700,000 | $185,170,000 | $77,154,000 | $23,908,000 |
Operating Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Operating Cash Flow | $179,105,000 | $188,814,000 | $80,395,000 | $26,037,000 |
| Cash Flow From Continuing Operating Activities | $179,105,000 | $188,814,000 | $80,395,000 | $26,037,000 |
| Operating Gains Losses | $-701,000 | $-4,336,000 | - | - |
Investing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Capital Expenditure | $-5,405,000 | $-3,644,000 | $-3,241,000 | $-2,129,000 |
| Investing Cash Flow | $195,792,000 | $-200,525,000 | $-43,866,000 | $8,766,000 |
| Cash Flow From Continuing Investing Activities | $195,792,000 | $-200,525,000 | $-43,866,000 | $8,766,000 |
| Cash From Discontinued Investing Activities | - | - | - | $0 |
Financing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Repurchase Of Capital Stock | $-300,278,000 | $0 | $0 | $0 |
| Financing Cash Flow | $-309,880,000 | $-11,072,000 | $-7,864,000 | $-13,695,000 |
| Cash Flow From Continuing Financing Activities | $-309,880,000 | $-11,072,000 | $-7,864,000 | $-13,695,000 |
| Net Other Financing Charges | $-12,001,000 | $-17,200,000 | $-12,089,000 | $-17,966,000 |
| Net Common Stock Issuance | $-300,278,000 | $0 | $0 | $0 |
| Issuance Of Capital Stock | - | - | - | $0 |
| Common Stock Issuance | - | - | - | $0 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Income Tax Paid Supplemental Data | $40,449,000 | $6,181,000 | $133,000 | $97,000 |
| End Cash Position | $162,314,000 | $97,296,000 | $120,078,000 | $91,413,000 |
| Beginning Cash Position | $97,296,000 | $120,078,000 | $91,413,000 | $70,305,000 |
| Effect Of Exchange Rate Changes | $1,000 | $1,000 | $0 | $0 |
| Changes In Cash | $65,017,000 | $-22,783,000 | $28,665,000 | $21,108,000 |
| Proceeds From Stock Option Exercised | $2,399,000 | $6,128,000 | $4,225,000 | $4,271,000 |
| Common Stock Payments | $-300,278,000 | $0 | $0 | $0 |
| Net Investment Purchase And Sale | $206,501,000 | $-196,881,000 | $-40,625,000 | $10,895,000 |
| Sale Of Investment | $376,840,000 | $232,813,000 | $122,709,000 | $122,372,000 |
| Purchase Of Investment | $-170,339,000 | $-429,694,000 | $-163,334,000 | $-111,477,000 |
| Net Business Purchase And Sale | $-5,304,000 | $0 | $0 | - |
| Purchase Of Business | $-5,304,000 | $0 | $0 | - |
| Net PPE Purchase And Sale | $-5,405,000 | $-3,644,000 | $-3,241,000 | $-2,129,000 |
| Purchase Of PPE | $-5,405,000 | $-3,644,000 | $-3,241,000 | $-2,129,000 |
| Change In Working Capital | $-11,775,000 | $-17,424,000 | $-59,491,000 | $-51,257,000 |
| Change In Other Working Capital | $425,000 | $648,000 | $-1,080,000 | $-3,280,000 |
| Change In Payables And Accrued Expense | $-20,344,000 | $26,596,000 | $60,836,000 | $20,024,000 |
| Change In Accrued Expense | $9,924,000 | $10,361,000 | $13,147,000 | $2,184,000 |
| Change In Payable | $-30,268,000 | $16,235,000 | $47,689,000 | $17,840,000 |
| Change In Account Payable | $-30,268,000 | $16,235,000 | $47,689,000 | $17,840,000 |
| Change In Prepaid Assets | $18,018,000 | $-22,930,000 | $57,000 | $675,000 |
| Change In Receivables | $-9,874,000 | $-21,738,000 | $-119,304,000 | $-68,676,000 |
| Changes In Account Receivables | $-9,874,000 | $-21,738,000 | $-119,304,000 | $-68,676,000 |
| Stock Based Compensation | $128,130,000 | $122,611,000 | $100,748,000 | $33,706,000 |
| Asset Impairment Charge | $16,396,000 | $19,934,000 | $13,794,000 | $9,783,000 |
| Deferred Tax | $-10,456,000 | $3,745,000 | $-6,615,000 | $-33,303,000 |
| Deferred Income Tax | $-10,456,000 | $3,745,000 | $-6,615,000 | $-33,303,000 |
| Depreciation Amortization Depletion | $3,175,000 | $2,281,000 | $1,601,000 | $1,301,000 |
| Depreciation And Amortization | $3,175,000 | $2,281,000 | $1,601,000 | $1,301,000 |
| Gain Loss On Investment Securities | $-2,115,000 | $-4,328,000 | - | - |
| Net Foreign Currency Exchange Gain Loss | $0 | $-8,000 | $0 | $0 |
| Gain Loss On Sale Of PPE | $1,414,000 | $0 | $0 | $0 |
| Net Income From Continuing Operations | $54,336,000 | $62,037,000 | $30,358,000 | $65,769,000 |
| Other Non Cash Items | - | $-34,000 | - | $38,000 |
| Repayment Of Debt | - | - | - | $0 |
| Issuance Of Debt | - | - | - | $0 |
| Interest Paid Supplemental Data | - | - | - | $0 |
| Net Issuance Payments Of Debt | - | - | - | $0 |
| Net Short Term Debt Issuance | - | - | - | $0 |
| Short Term Debt Payments | - | - | - | $0 |
| Short Term Debt Issuance | - | - | - | $0 |